Sabra Healthcare REIT Inc (NASDAQ:SBRA) currently has a daily average trading volume of 2.17M but it saw 2619409 shares traded in last market. With a market cap of 4.01B USD, the company’s current market price of $16.86 came rising about 1.63 while comparing to the previous closing price of $16.59. In past 52 weeks, the stock remained buoying in the range of price level as high as $19.99 and as low as $13.22. In the recent trading on the day, stock has struck highest price mark of $16.605 while lowest mark touched by it was $17.13.
Taking a look at 20-day trading activity of Sabra Healthcare REIT Inc (SBRA) gives us an average price of $16.59, while its current price level is -15.66% below from 52-week high level whereas it is 27.55% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $16.74 while that of 200 days or SMA-200 reads an average of $16.99. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.05% during that period while stretching the period over a month that decreases to 2.90%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.73 which implies that the stock is in neutral territory.
JMP Securities upgraded its recommendation for the stock as a “Mkt Outperform” from “Mkt Perform” on January 07, 2025 while assigning a price target of $20. Mizuho also issued its recommendations for the stock as it downgraded the price target for the stock is $20.
Over the week, SBRA’s stock price is moving 1.75% up while it is 3.82% when we observe its performance for the past one month. Year-to-date it is -2.66% down and over the past year, the stock is showing an upside performance of 21.48%.
The company is expected to be releasing its next quarterly report on 2025-Feb-18, for which analysts forecasted an EPS of 0.17 while estimate for next year EPS is 0.7. In next quarter, company is expected to be making quarterly sales of $180.41M as analysts are expecting the sales for current fiscal year at $734.48M and seeing the company making $769.23M in sales next year. Moreover, analysts are in estimates of $178.57M for current-quarter revenue.
Currently, Sabra Healthcare REIT Inc’s total number of outstanding shares is 237.59M with 1.30% of that held by the insiders while 100.58% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 2.44% and return on equity (ROE) at 4.57%. It has a price to earnings ratio (P/E ratio) of 31.48 while having a 21.70 of forward P/E ratio. Stock’s beta reads 0.93. Stock has a price to book (P/B) ratio of 1.46 while price to sale or P/S ratio amounts to 5.72. Its return on asset (ROA) is 2.37% on average.
